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Abstract
Human pluripotent stem cells (hPSCs) are required in large numbers for various biomedical
applications.However, the scalable and cost-effective culturing of high quality hPSCs and their
derivatives remains very challenging.Here, we report a novel and physiologically relevant 3D culture
system (called the AlgTube cell culture system) for hPSC expansion and differentiation.With this
system, cells are processed into and cultured inmicroscale alginate hydrogel tubes that are suspended
in the cell culturemedium in a culture vessel. The hydrogel tubes protect cells fromhydrodynamic
stresses in the culture vessel and limit the cellmass smaller than 400 μmin diameter to ensure efficient
mass transport, creating cell-friendlymicroenvironments for growing cells. This system is simple,
scalable, highly efficient, defined and compatible with the current goodmanufacturing practices.
Under optimized culture conditions, theAlgTubes enabled long-term culture of hPSCs (>10 passages,
>50 days)with high cell viability, high growth rate (1000-fold expansion over 10 days per passage),
high purity (>95%Oct4+) and high yield (5.0×108 cells ml−1), all of which offer considerable
advantages compared to current approaches.Moreover, the AlgTubes enabled directed differentiation
of hPSCs into various tissue cells. This system can be readily scaled to support research frombasic
biological study to clinical development and the future industry-scale production.
Introduction
Human pluripotent stem cells (hPSCs), including
human embryonic stem cells (hESCs) and induced
pluripotent stem cells (iPSCs), are attractive cell
sources for various biomedical applications including
cell therapies [1], tissue biofabrication [2–4], drug
screening and toxicity tests [5, 6]. These applications
require large numbers of high quality cells [7]. For
instance, it is estimated that∼109 cardiomyocytes, 109
β cells, 1012 red blood cells, and 1011 platelets are
needed for treating one myocardial infarction or
diabetic patient, or one blood or platelet transfusion,
respectively [1]. Approximately 1010 cells are required
for engineering a human-size heart or liver [5], or for
screening a library with one million compounds once
[6]. Considering the large patient population and the
large numbers of chemical libraries that can be
screened, massive numbers of cells are therefore
needed [7].
However, the scalable and cost-effective culturing
of high quality hPSCs and their derivatives, especially
for clinical applications, remains a challenge [1, 7, 8].
In vivo, majority of human cells including the hESCs
reside in 3D microenvironments that have plenty of
cell–cell and cell–ECM (extracellular matrix) interac-
tions, sufficient supply of nutrients, oxygen and
growth factors, and no or minimal hydrodynamic
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stresses [9–13]. The current hPSC culturing methods,
however, provide culturing conditions that are very
different from these physiological microenviron-
ments, leading to low culture efficiency and difficulty
to culture cells at large scales. Two-dimensional (2D)
cell culturing (e.g. with cell culture flasks) is the most
widely used method for culturing hPSCs. However, a
2D environment is very different from an in vivo
environment. Additionally, 2D culturing is labor-,
space- and reagent-consuming, and considered only
suitable for preparing small scale cells [1, 7, 8]. Three-
dimensional (3D) suspension culturing (e.g. with stir-
red-tank bioreactors), in which cells are suspended in
the culture medium, has been widely studied to scale
up the production and has achieved some attractive
results [1, 7, 8]. However, a critical problem with 3D
suspension culturing is the uncontrolled cell agglom-
eration (figures S1(A) and (B) are available online at
stacks.iop.org/BF/10/025006/mmedia) [1]. hPSCs
have strong cell–cell interactions that make them
aggregate [12, 13]. Suspended single hPSCs first
associate to form small cell clusters (i.e., initial cell
clustering), which is important for the survival and
growth of dissociated hPSCs [12, 13]. These small cell
clusters grow as spherical aggregates (i.e., spheroids)
when cells divide. Spheroids, however, frequently fuse
to each other to form large cell agglomerates (i.e.,
agglomeration) (figures S1(A) and (B)). Agglomera-
tion leads to inhomogeneity in cell aggregate size and
is detrimental to cell culture [1]. For instance, the
transport of nutrients, oxygen, and growth factors to,
and the metabolic waste from cells located at the cen-
ter of large cell agglomerates (e.g.,>400 μmdiameter)
become insufficient, leading to slow cell growth, apop-
tosis, and uncontrolled differentiation [1, 14]. While
agitating the culture can enhance mass transport and
reduce cell agglomeration, agitation also generates cri-
tical hydrodynamic stresses (e.g. shear stresses) that
negatively impacts cells [1, 15, 16]. With the uncon-
trolled cell aggregation and hydrodynamic stresses,
significant cell death, low cell growth and low volu-
metric yield are common in 3D suspension culturing
[7]. For instance, we and others showed hPSCs typi-
cally expanded 4-fold in 4 days to yield around
2.0×106 cells ml−1 (table S1) [17–19]. These cells
occupy∼0.4%of the bioreactor volume [20].
Furthermore, the hydrodynamic conditions (e.g.
the medium flow direction, velocity, shear force and
chemical environment) generated by the agitation in
3D suspension culturing are very complicate [1, 7, 8,
15–19, 21]. They are spatially and temporally varied,
and sensitive to many factors including the bioreactor
design (e.g. impeller geometry, size and position, ves-
sel geometry and size, positions of probes for pH,
temperature, oxygen), medium viscosity and agitation
rate [1, 21]. They are currently not well understood
and hard to control [1, 15, 16, 21]. Additionally, how
cells respond to these complicate hydrodynamic con-
ditions is not well known and is hard to study
[1, 15, 16]. These complicate conditions and knowl-
edge gap lead to culture inconsistency and difficulty in
scaling up, as shown by recent studies on producing
cardiomyocytes from hPSCs in stirred-tank bior-
eactors [22, 23]. For three batches (∼100 ml suspen-
sion cultures) using a hESC line, the final yield ranged
from 40million to 100 million cells, and final cardio-
myocyte purity ranged from 54% to 84%. Using the
same bioreactor and a different hPSC line, the final
yield ranged from 89 million to 125 million cells, and
final cardiomyocyte purity ranged from 28% to 88%
[22, 23]. When the culture volume was scaled from
∼100 ml to ∼1000 ml, the yield and differentiation
efficiency were altered. Re-optimizing bioreactor
design, agitation rate and culture protocol was
required [22, 23]. This indicates the challenge of fur-
ther scaling up the culture volume (e.g. to hundreds
liters) since optimizing multiple factors in large cul-
ture volume is costly. To our best knowledge, the lar-
gest 3D suspension culture volume demonstrated to
date for hPSCs is less than 10 l [1, 24].
Researchers have tried to encapsulate and culture
hPSCs in various hydrogel scaffolds with the goal of
using scaffolds as physical barriers to isolate cells from
agglomeration and hydrodynamic stresses [7, 17,
25–29]. We recently found hPSCs could be effectively
cultured in a very soft and thermoreversible hydrogel
matrix (Mebiol® Gel) [7, 17, 29]. Within this hydrogel
matrix, single hPSCs clonally grew into uniform
spheroids (diameter ∼100–150 μm) (figures S1(C)
and (D)). The hydrogel scaffold enabled serial expan-
sion of hPSCs with good cell viability, growth rate (e.g.
20-fold/5 days), yield (e.g. 2.0×107 cells ml−1) and
purity, all of which offered improvements over 3D
suspension cultures. However, this system has some
limitations that make it inappropriate for large-scale
cell production. First, it is not universally applicable.
For some hPSC lines and human cell types, the dis-
sociated cells cannot survive and clonally grow in the
hydrogel. Though the exact reason is still unknown,
we speculate that the scaffold prevents the initial cell–
cell interactions that are important for cell’s survival
[7, 17, 29]. Second, the volumetric yield and expansion
per passage are moderate, probably due to the fact that
cells encapsulated in hydrogels have no free space for
expansion and they have to deform scaffolds to create
spaces for the new cells [7, 17, 29]. Third, the hydrogel
is mechanically fragile, making it hard to be processed
into formats (e.g., beads) suitable for large-scale cell
cultures. And lastly, the hydrogel remains stable for
about twoweeks, which prohibits its use for long-term
cell culture, such as differentiating hPSCs into neu-
rons, which requires more than one month. The
results of this study showed that eliminating the cell
agglomeration and hydrodynamic stresses could sig-
nificantly improve the culture efficiency, however, free
spaces that allow the initial cellular interactions and
subsequent cell expansion were also important to
achieve high culture outcomes.
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We here report a novel technology that can over-
come the limitations of current hPSC culturing meth-
ods and provide physiologically relevant cell culture
microenvironments. With this technology, hPSCs are
processed into and cultured in microscale alginate
hydrogel tubes (or AlgTubes) that are suspended in the
cell culture medium in a culture vessel (figures 1(A)
and (B)). The hydrogel tubes create cell-friendly
microspaces that allow cells to interact with each other
and expand. Meanwhile, they protect cells from
hydrodynamic stresses in the culture vessel and con-
fine the cell mass less than 400 μm (in radial diameter)
to ensure efficient mass transport during the entire
culture (figures 1(A) and (B)). Additionally, this
Figure 1.Overview of theAlgTube cell culture system. (A), (B)Design principles of AlgTubes. Cells are processed into and cultured in
microscale alginate hydrogel tubes that are suspended in the cell culturemedium in a culture vessel. The hydrogel tubes protect cells
fromhydrodynamic stresses (e.g. shear stresses) in the culture vessel and confine the cellmass less than 400 μm (in radial diameter) to
ensure efficientmass transport. They also create physiologically relevantmicrospaces for cells to interact with each other and expand.
Cell culturemedium can efficiently diffuse through the alginate hydrogel shell. An illustration (A) andmicroscope picture (B) of an
AlgTube are shown. (C)–(E)ExtrudingAlgTubes. The setup for extrudingAlgTubes consists of two syringe pumps, a custom-made
micro-extruder and aCaCl2 buffer. TomakeAlgTubes, a cell solution (e.g. single cells suspended in hyaluronic acid solution) and an
alginate solution is pumped into the central channel and side channel of themicro-extruder, respectively, to form coaxial core–shell
flows that are extruded through the nozzle of themicro-extruder into theCaCl2 buffer. The shell alginateflow is instantly crosslinked
byCa2+ ions to form an alginate hydrogel tube. (F)Proposed cell growthmechanism inAlgTubes. After extruding theAlgTubes,
individual cells first associate to form small cell clusters (i.e. the initial clustering phase). Subsequently, cells proliferate and the small
cell clusters expand to form fibrous cellmass (i.e. the cell expansion phase). (G)Thismechanismwas confirmedwith experiment. Two
vials ofH9-hESCs, stainedwith blue and green fluorescent dyes, respectively, weremixed at 1:1 and cultured inAlgTubes. Single cells
(day 0), small cell clusters (day 1), andfibrous cellmass (day 9)were seen. (H), (I)ROCK inhibitors (RIs) are required for the survival of
singleH9-hESCs. Live/dead staining showedmajority of cells went apoptosis after 24 hwithout RIs (−RI) (H). Cells survived and
grewwell with RIs (+RI) (I). Scale bar: 200 μm.
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technology is simple, scalable, defined and compatible
with the current good manufacturing practices that
make it commercially viable. We showed that, under
optimized culture conditions, the AlgTubes offered
paradigm-shifting improvements in cell viability,
growth, yield, culture consistency and scalability over
current hPSC culturing technologies.
Methods
Materials
Fib-iPSCs and MSC-iPSCs were obtained from
Human Embryonic Stem Cell Core, Harvard Medical
School. MSC-iPSCs and Fib-iPSCs were repro-
grammed from mesenchymal stem cells and fibro-
blasts, respectively, by George Q. Daley Lab
(Children’s Hospital Boston, MA) and have been well
characterized and described in the literature [56]. H9-
hESCs (Cat #: WA09) were purchased from WiCell
Research Institute. Authentication and test for the free
of mycoplasma were performed by WiCell Research
Institute. A cell bank was established after we received
the cells for each line. For experiments, each aliquot
from the cell bank was used for less than 10 additional
passages. For hPSCs, the cell growth kinetics and
expression of pluripotency markers (e.g. Oct4,
Nanog), karyotype, and differentiation capability were
tested to ensure these cells had no major genetic
mutation or loss of their differentiation capabilities. L
Wnt3A cells (ATCC® CRL-2647™) were acquired
fromATCC.
Reagents and their supplies: PNIPAAAm-PEG (cat
#MBG-PMW20-5005, Cosmobio USA); E8 medium
(cat # A1517001, life technologies); Accutase: (cat #
A1110501, life technologies); Y-27632 (cat# 129830-
38-2, Sigma); Matrigel (cat # 08-774-552, Corning);
Sodium Hyaluronate: (cat # HA 700K-5, Lifecore
Biomedical); Methylcellulose stock solution (cat #
HSC001, R&D system); Sodium alginate (cat # 194-
13321, 80–120cp, Wako Chemicals). Vybrant multi-
color cell-labeling kit (cat # V22889, Molecular
Probes); DMEM (cat# SH30003.03, GE Healthcare);
FBS (cat # s11150, Atlanta biologicals); G418 (cat #
BP6731, Fisher); Luciferase report assay kit (cat #
K801-200, Biovision); Calcein AM viability dye (cat#
50-169-52, eBiosicence); Ethidium homodimer I (cat
# 40010, Biotium); DAPI (cat # D9542, Sigma).
RNeasy mini kit (cat # 74104 QIAGEN). Propidium
Iodide (cat # 195458, MP Biomedicals, LLC). Anti-
bodies used in this studywere summarized in table S2.
Culturing hPSCs in 3DPNIPAAm-PEGhydrogel
hPSCs cells were maintained in PNIPAAm-PEG
hydrogel before culturing in AlgTubes as described in
our previous publications [7]. Briefly, single hPSCs
cells weremixedwith 10%PNIPAAm-PEG solution at
4 °C and cast on a 12-well plate, then incubated at
37 °C for 15 min to form a stable hydrogel before
adding warm E8 medium plus 10 μM Y-27632 (Rock
inhibitor). To passage cells, 2 ml of ice cold PBS was
added to each well for 2 min to dissolve the hydrogel.
Spheroids were collected by centrifuging at 100 g for
3 min, treated with Accutase at 37 °C for 12 min and
dissociated into single cells with pipettes.
ProcessingAlgTubes
A custom-made micro-extruder was used to process
AlgTubes. A hyaluronic acid (HA) or methylcellulose
(MC) solution containing single cells and an alginate
solution was pumped into the central and side channel
of the home-made micro-extruder, respectively, and
extruded into a CaCl2 buffer (100 mM) to make
AlgTubes. Subsequently, theCaCl2 bufferwas replaced
by cell culturemedium.
Culturing hPSCs in theAlgTubes
For a typical cell culture, 20 μl of cell solution in
AlgTubes were suspended in 2 ml E8 medium in a
6-well plate and cultured in an incubator with 5%
CO2, 21%O2 at 37 °C.Mediumwas changed daily. To
passage cells, medium was removed and alginate
hydrogels were dissolved with 0.5 mM EDTA for
5 min. Cell mass was collected by centrifuging at 100 g
for 5 min, treated with Accutase at 37 °C for 12 min
and dissociated into single cells for following culture.
Culturing L-Wnt3A-cells inAlgTubes
For a typical cell culture, 20 μl of cell solution in
AlgTubes were suspended in 2 ml DMEM medium
plus 10% FBS in a 6-well plate and cultured in an
incubator with 5% CO2, 21% O2 at 37 °C. Medium
was changed daily and collected for quantifying
Wnt3A proteins. To quantify Wnt3A proteins, MDA-
468 cells (ATCC® HTB-132™) were stably transfected
with a luciferase reporter for the canonical Wnt
signaling (Addgene, # 24308). These MDA-468-TFP
cells were plated in a 96 well plate (5000 cells/well/
200 μl medium). 24 h later, 150 μl of fresh DMEM
plus 10% FBS and 50 μl of L-Wnt3A-cells conditioned
medium was added and incubated for another 18 h.
Mediumwas then removed and cells were washedwith
PBS once before 200 μl of cell lysis buffer was added
and incubated for 10 min at room temperature. 50 μl
of cell lysates, 50 μl of substrate A and 50 μl of
substrate B from the luciferase assay kit were mixed
and the light signals were immediately read with a
luminometer. The quantity of Wnt3A protein was
calculatedwith a standard curve.
Culturing hPSCs in theAlgTubeswith bioreactor
2 ml of cell solution in AlgTubes were suspended in a
home-made bioreactor. Cells were cultured in an
incubator with 5% CO2, 21% O2 at 37 °C for 10 days.
Medium was stored in a bellow bottle that was
periodically pressed to flow the medium into, or
released towithdraw themedium from, the container.
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Staining,flow cytometry and imaging
Cells cultured on 2D surfaces were fixed with 4%
paraformaldehyde (PFA) at room temperature for
15 min, and permeabilized with 0.25% Triton X-100
for 15 min, and blocked with 5% donkey serum for
1 h. Cells were then incubatedwith primary antibodies
at 4 °C overnight. After extensive washing, secondary
antibodies and 4′,6-diamidino-2-phenylindole, dihy-
drochloride (DAPI) were added and incubated for
another 1 h at room temperature. Cells were washed
with PBS three times before imaging with a Zeiss Axio
Observer Fluorescent Microscopy. The percentage of
Oct4+nuclei was quantifiedwith Image J software. At
least 1000 nuclei were analyzed. To stain 3D fibrous
cell mass, the cell mass was harvested and fixed with
4% PFA at room temperature for 30 min, and then
incubated with PBS+0.25% Triton X-100+5%
goat serum+primary antibodies at 4 °C for 48 h.
After extensive washing, secondary antibodies in 2%
BSA were added and incubated at 4 °C for 24 h. Cells
were washedwith PBS three times before imaging with
Nikon A1 Confocal Microscopy. For flow cytometry,
single cells were fixed with 4% paraformaldehyde
(PFA) at room temperature for 15 min, permeabilized
with 0.25%TritonX-100 for 15 min, and blockedwith
5% donkey serum for 1 h. Cells were then incubated
with primary antibodies at 4 °C overnight. After
extensive washing, secondary antibodies were added
and incubated for another 2 h at room temperature.
Cells were washed with PBS two times before assess-
ment using Cytek DxP 10 flow cytometer (BD
Biosciences). Analysis was performed using FlowJo.
LIVE/DEAD®Cell Viability staining was used to assess
live and dead cells, according to the productmanual.
EBdifferentiation
hPSCs released from the AlgTubes were suspended in
DMEM+20% FBS+10 μM β-mercaptoethanol in
a low adhesion plate for 6 days. The cell masses were
then transferred into plates coated with 0.1% gelatin
and cultured in the same medium for another 6 days,
followed by fixation and staining as above.
Teratoma formation in vivo
All animal protocols were approved by the Institu-
tional Animal Care and Use Committee of the
University of Nebraska–Lincoln. All experimental
procedures involving animals were performed in
accordance with the guidelines of the Institutional
Animal Care and Use Committee of the University of
Nebraska–Lincoln. 2×106 hPSCs were suspended in
25 μl of PBS plus 25 μl of Matrigel and injected
subcutaneously at the back of the neck of the NOD-
SCID mice (female, age 7 weeks, Charles River
Laboratory). Tumors were harvested after 6–12 weeks.
The tumors were fixed with 4% PFA for 48 h and
sequentially dehydrated with 70%, 95%, and 100%
ethanol, and deffated with xylene for 2 h before
embedding in paraffin. Then, 10 μm thick sections
were cut and stainedwith hematoxylin and eosin.
Karyotype
Karyotyping was performed by WiCell Research
Institute.
Mesodermal induction
hPSCs in AlgTubes were cultured in E8 medium for 7
days, and then in DMEM/F12 medium with 1% B27
minus insulin and 12 μM CHIR99021 for 24 h before
fixation and staining.
Endodermal induction
hPSCs cells in AlgTubes were cultured in E8 medium
for 7 days; then in RPMI 1640 medium with 1%
GlutaMAX, 1% B27 minus insulin and 4 μM
CHIR99021 for 24 h; then in RPMI 1640mediumwith
1% GlutaMAX and 1% B27 minus insulin for an
additional 24 h before fixation and staining.
Cardiomyocyte differentiation
hPSCs cells in AlgTubes were cultured in E8 medium
for 7 days, then in DMEM/F12 with 1% B27-insulin
for 6 days, then DMEM/F12 with 1% B27 for 9 days.
The following small molecules were added during the
differentiation: 12 μMCHIR99021 for days 0–1; 5 μM
IWR1 for days 3–4. Cell mass were released on day 11
to a 6-well plate. Beating cardiomyocytes were filmed
on day 15.
Direct comparison of culturing hPSCs in 2D, static
3D and dynamic 3D suspension and theAlgTubes
For 2D culturing, 2×105 hPSCs were seeded in six-
well plate coatedwithMatrigel and cultured for 7 days.
For static 3D suspension, 2×105 cells ml−1 hPSCs
were suspended in low attachment 6-well plates and
cultured for 7 days. For dynamic 3D suspension,
2×105 cells ml−1 hPSCs were suspended in a spinner
flasks (∼75 rpm) and cultured for 7 days. For Alg-
Tubes, 1×106 cells ml−1 hPSCs were seeded and
cultured for 9 days. The culture medium was changed
daily and collected formeasuring dead cells. Adenylate
kinases (AKs) are ubiquitous proteins present in all
eukaryotic and prokaryotic cells. They are rapidly
released into the culture medium upon damage of the
plasma membrane of cells. AKs in the cell culture
medium were quantified with the bioluminescence
cytotoxicity assay kit (cat # JM-K312-500, MBL
medical & biological laboratories) according to the
product instruction, and normalized with a standard
curve to calculate the dead cells in the culture medium
every 24 h. Samples were harvested and live cells were
counted with trypan blue. Single cells were fixed with
70% ethanol for cell cycle analysis with propidium
iodide staining and flow cytometry.
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RNA sequencing and data analysis
Total RNAs of day 3 hPSCs cultured in 2D, static 3D,
dynamic 3D andAlgTubes were preparedwith RNeasy
mini kit (cat # 74104 QIAGEN) according to the
manufacturer’s instruction. Libraries were prepared
with TruSeq Stranded mRNA Library Prep Kit and
sequenced with Illumina NextSeq 500. 20 million
75 bp paired-end reads were generated for each
sample. The reads were trimmed to make sure the
average quality score was larger than 30 and the
minimum length was 40 bp. All trimmed short reads
were mapped to the human Genome (version hg19)
using TopHat, allowing up to two base mismatches
per read. Reads mapped to multiple locations were
discarded. Numbers of reads in genes were counted by
the HTSeq-count tool using corresponding human
gene annotations and the ‘union’ resolution mode.
For normalization and pair-wise comparisons, differ-
entially expressed genes were identified by using
DEseq to analyze the numbers of reads aligned to
genes. The thresholds for differential expression were
set at fold-change >2 and adjusted P-values <0.001
for the null hypothesis.
Principle component analysis (PCA) analysis
PCA was implemented with R function prcomp and
the 3D PCA plot was produced with R package rgl. For
PCA analysis, genes with zero reads were discarded
and a natural log transformation was applied to the
number of reads for each gene. The proportion of total
variance accounted for by the first three PCs was
64.46% (PC1 29.75%, PC2 18.06%, PC3 16.64%),
which suggested that those three PCs are sufficient to
describe the major changing pattern of all samples.
Heatmap for gene expression. For each pathway, the
expression values of genes in the given pathway were
extracted and, to further stabilize the variance, a
natural log transformation was applied to normalized
read numbers for genes. The heatmap of expression
profiles for genes in a given pathway was plotted with
R package heatmap. In the heatmap, red indicates high
expressionwhile green represents low expression.
Statistical analysis
The data are presented as the mean±S.D.. We used
an unpaired t-test to compare two groups and one-
way ANOVA to compare more than two groups.
P<0.05 was considered statistically significant.
Homogeneity of variances among groups were con-
firmed using Bartlett’s test. Conformity to normal
distribution was confirmed using the Kolmogorov–
Smirnov test. For in vitro experiments, a sample size of
3 or 5 was selected so that at a significance level of 0.05
there at is least a 90% chance of detecting a two
standard deviation difference in cell numbers between
the groups.
Data availability
The final processed data and raw fastq files were
submitted to Gene Expression Omnibus (GEO) with
the accession number GSE99776. All other data
supporting the findings of this study are available
within the paper and its Supplementary Information.
Results
A micro-extruder was designed and made for proces-
sing AlgTubes (figure 1). To make AlgTubes, a cell
solution and an alginate solution is pumped into the
central channel and side channel of the micro-
extruder, respectively, to form coaxial core–shell flows
that are extruded into aCaCl2 buffer. The shell alginate
flow is instantly crosslinked by Ca2+ ions to form an
alginate hydrogel tube (figures 1(C)–(E)). Subse-
quently, the CaCl2 buffer is replaced by the cell culture
medium and cells are grown in the tubes. The micro-
extruder can have multiple nozzles for simultaneously
processing multiple AlgTubes to make large-scale
AlgTubes (figure S2, and supplementary video 1). It
was found that the cell solution and alginate solution
should have close viscosity to process defect-free
AlgTubes. Both hyaluronic acid (HA) and methylcel-
lulose (MC) solutions could be used to suspend cells
for this purpose. Similar to 3D suspension culturing
(figures S1(A) and (B)), single hPSCs in AlgTubes
quickly (e.g. within 24 h) associated to form small cell
clusters that subsequently grew and filled the tubes
(figures 1(F) and (G)). We termed these two phases as
the initial clustering phase and subsequent cell expan-
sion phase, respectively. In 2D and 3D suspension
culturing of hPSCs, ROCK inhibitors (e.g. Y-27632)
are added to the culture medium for the first 24 h after
passaging to inhibit the dissociation-induced cell
death [30]. We found ROCK inhibitors (Y-27632)
were also required for the survival and growth of the
single hPSCs in AlgTubes. Without ROCK inhibitors,
majority of cells diedwithin 24 h (figures 1(H) and (I)).
To passage cells, the AlgTubes could be dissolved with
the cell-compatible ethylenediaminetetraacetic acid
(EDTA) solution (0.5 mM, 5 min at room temper-
ature) to release the micro cell mass, which could be
further treated with Accutase (10 min at 37 °C) and
dissociated into single cells for the following passage.
We found AlgTubes made with a wide range of
alginate concentrations, tube diameters and hydrogel
shell thicknesses all supported efficient culturing of
hPSCs (figures S3–S5). For instance, hPSCs grew effi-
ciently and similarly in AlgTubes made with 1.0%,
1.5% and 2.0% alginate solutions (figure S3). When
seeded at 1.0×107 cells ml−1, cells expanded ∼14-,
23- and 50-fold to yield ∼1.4×, 2.3×and
5.0×108 cells ml−1 on day 5, 7 and 9 of the culturing
with above 94% cells expressed the pluripotency mar-
ker Oct4 at all three alginate concentrations. The Alg-
Tube’s outer diameter is roughly equal to the inner
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diameter of the nozzle of the micro-extruder and can
be controlled through adjusting the nozzle’s diameter
(figure S2). At a given AlgTube outer diameter, the
hydrogel shell thickness could be controlled by varying
the ratio of the cell solutionflow rate and alginate solu-
tion flow rate and predicted by using the equation
described in figure S4(A). When seeded at
1.0×107 cells ml−1 and cultured in AlgTubes (with
∼400 μm diameter) with 30, 40, and 70 μm shells or
AlgTubes (with 30–50 μm shells) with diameter of
400 μm, 250 μm and 120 μm for 9 days, hPSCs all
expanded around 50-fold to yield
∼5.0×108 cells ml−1 with above 90% cells retained
the pluripotency marker Oct4 (figures S4 and S5).
Since both HAs and MCs could be used to suspend
cells, we studied whether they differentially influenced
cell culture. Our research showedHAs andMCs resul-
ted in similar cell viability, expansion and plur-
ipotency (figure S6). The capability to support
consistent hPSC culturing under a wide range of Alg-
Tube conditions gives users large flexibility in proces-
sing the tubes.
AlgTubes supported efficient hPSC culturing with
a wide range of seeding densities (figures 2 and S7).
When seeded at 1.0×, 2.0×, 5.0×, and
10.0×106 cells ml−1, hPSCs expanded 499-, 247-,
104- and 51-fold by day 9, respectively, yielding
around 5.0×108 cells ml−1 (figure 2). For all condi-
tions, cells grew through the initial clustering phase
and the subsequent cell expansion phase. At 24 h after
processing the AlgTubes, the cell cluster size was larger
for higher seeding density but the numbers of cell clus-
ters per volume were similar for different seeding den-
sities (figure 2(A)). These results showed hPSCs grew
faster at lower seeding density (figures 2(B) and (C)).
However, the seeding density did not influence plur-
ipotency.>95% cells expressed the pluripotency mar-
ker Oct4 for all seeding densities (figures 2(D) and
(E)). It is extremely exciting that hPSCs seeded at
ultralow densities could grow as well without sacrifi-
cing cell viability and pluripotency (figure S7). When
seeded at 1.0×, 3.0×and 5.0×105 cells ml−1,
hPSCs expanded 4200-, 1700- and 1000-fold to yield
∼4.2×, 5.1×, and 5.0×108 cells ml−1 by days 14, 12
and 10, respectively.
After performing these optimizations, the Alg-
Tubes were evaluated for culturing multiple hPSC
lines for long-term (e.g. 10 passages, figures 3, S8 and
S9). All hPSCs grew well in AlgTubes, and cell morph-
ology, viability, growth rate, and pluripotency among
multiple hPSC lines were similar. In the 10-passage
culture, when seeded at 1.0×107 cells ml−1, hPSCs
consistently expanded ∼15-fold/passage/5 days and
>95%of cells expressed the pluripotencymarkerOct4
(figures 3(A) and (B)). The long-term culture did not
alter cell phenotype as shown by the similar cell
morphology, viability, growth kinetics and plur-
ipotency of hPSCs at passage 1 and 10 (figures 3, S8
and S9). When seeded at 1.0×107 cells ml−1, hPSCs
expanded ∼50-fold to yield 5.0×108 cells ml−1 on
day 9 at both passage 1 and 10. In vitro embryoid body
(EB) differentiation and in vivo teratoma formation
confirmed their pluripotency after the long-term cul-
ture. All hPSCs were successfully differentiated into
endodermal, mesodermal and ectodermal cells in the
EB assay (figures 4(A), S10(A) and (B)). All hPSCs
formed teratomas containing the three germ layer tis-
sues in immune-deficient mice in the teratoma assay
(figures 4(B), S10(C) and (D)). In addition, after long-
term culture, all hPSCs retained normal karyotypes
(figures 4(C), S10(E) and (F)). These results show that
AlgTubes can support long-term culturing of hPSCs.
After expansion and further culturing in a meso-
dermal [31, 32] or endodermal [33] or cardiomyocyte
[31, 32] differentiation medium, hPSCs in the Alg-
Tubes could be differentiated to corresponding meso-
dermal or endodermal cells or cardiomyocytes at high
efficiency, indicating the AlgTubes support hPSC dif-
ferentiation (figures 4(D)–(F), and supplementary
video 2). Additionally, cells other than hPSCs can be
cultured in the AlgTubes. For instance, murine L cells
engineered to express Wnt3A proteins were efficiently
cultured without notable cell death [34], yielding
around 6.0×108 cells ml−1 (figure S11). Wnt3A pro-
teins were consistently expressed during a 16 day cul-
ture. These results demonstrate AlgTube’ potential as
a generally applicable culture system.
A prototype bioreactor was built to show Alg-
Tubes’ scalability (figure 5). Two milliliters of Alg-
Tubes with hPSCs were processed and contained in a
bioreactor. The cell culture medium was stored in a
plastic bellow bottle that could be pressed to flow the
medium into the bioreactor or released to withdraw
the medium from the bioreactor, respectively
(figure 5(A)). The pressing and releasing speed, as well
as the duration of the interval between the pressing
and releasing can be programmed and controlled by
the controller (figure 5(B)). Since AlgTubes have simi-
lar density with the cell culture medium, they were
uniformly suspended and dispersed in the medium
when the medium was pumped into the bioreactor.
They became collected and contact with each other
when the medium was withdrawn from the bior-
eactor. This alternating dispersion and collection is
designed to enhance the medium mixing. Within the
bioreactor, hPSCs grew well and yielded
∼5.0×108 cell ml−1 by day 10 (figures 5(C) and (D)).
>95% of cells expressed the pluripotency markers
(figures 5(E) and (F)). This prototype bioreactor could
be further scaled up in the future.
To assess the superiority of the AlgTubes over cur-
rent hPSC culturing technologies, we directly com-
pared culturing hPSCs in 2D, 3D suspension without
agitation (static 3D), 3D suspension with agitation
(dynamic 3D) and the AlgTubes (figure 6). Cells were
cultured for 9 days in AlgTubes to allow cells to fill the
tubes. Cells were cultured for 7 days in 2D, static 3D
and dynamic 3D culturing since the cell numbers had
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Figure 2.The growth kinetics ofH9-hESCs seeded at various seeding densities in AlgTubes. H9-hESCswere seeded at 1×, 2×, 5× or
10×106 cells ml−1 in AlgTubes and cultured for 9 days. (A)Phase images of cells on day 0, 1, 5 and 9 inAlgTubes. After 24 h, single
cells formed small clusters. The cell clusters were bigger at higher seeding density, but the number of clusters were similar (insert, day
1). Clusters grew into spheroids (day 5) and thenfibrous cellmass (day 9). (B)The expansion fold on day 5, 7 and 9 showed hPSCs grew
faster at lower seeding density, (C)while thefinal volumetric yields on day 9were very close. (D) Immunostaining showed∼95% cells
expressed the pluripotencymarkerOct4 after the 9 day culture.H9-hESCswere released fromAlgTubes on day 9 and plated on a
Matrigel-coated plate overnight before fixing and staining. (E)%ofOct4+cells were quantifiedwith Image JData are presented as
mean±SD of three independent replicates (n=3). Scale bar: (A) 400 μm; (D) 50 μm.
8
Biofabrication 10 (2018) 025006 QLi et al
no further increase after 5 days in these cultures. Med-
ium was changed daily. Live cells in the cultures were
counted daily. Cells died in each day were quantified
through measuring the adenylate kinases (AKs) in the
exhausted cell culture medium. AKs, which are ubi-
quitous proteins presented in cells, are rapidly released
into the culture medium upon damage of the plasma
membrane. The ratio of dead cells over the dead cells
Figure 3.AlgTubes supported long-term culturing of hPSCs.H9-hESCs, Fib-iPSCs andMSC-iPSCswere cultured in theAlgTubes for
10 passages. Fib-iPSCs andMSC-iPSCs are iPSCsmade fromhuman fibroblasts andmesenchymal stem cells, respectively. (A)When
seeded at 1.0×107 cells ml−1, all three hPSCs consistently expanded∼15-fold per passage per 5 days and (B)>95%of the cells
expressedOct4 during the 10-passage culturing. Data are presented asmean±SDof three independent replicates (n=3). (C)–(H)
The growth kinetics of hPSCs at Passage 10. (C)Phase images of day 0, 3 and 5H9-hESCs and (D) live/dead staining of day 7H9-
hESCs inAlgTubes. (E), (F) Seeded at 1.0×107 cells ml−1, all three hPSCs expanded∼15-, 24-, 53-fold to yield∼150×, 240×,
530×106 cells ml−1 on day 5, 7 and 9, respectively. Data are presented asmean±SD offive independent replicates (n=5). (G)
Confocalmicroscope images and (H)flow cytometry analysis showedmajority cells on day 9 at passage 10 expressed pluripotency
markers: Nanog,Oct4, SSEA-4 and alkaline phosphatase (ALP). Scale bar: (C), (D) 400 μm; (G) 100 μm.
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plus the live cells was calculated (e.g. the % dead cells)
and used to assess the cell viability each day. Cell pro-
liferation was also evaluated through quantifying the
percentage of cells in S and G2/M phases. Seeded at
2.0×105 cells ml−1, hPSCs expanded only 5-fold to
yield amaximumof∼1.0×106 cells ml−1 in static 3D
culturing. At the same seeding density, hPSCs expan-
ded ∼9-fold to yield a maximum of
∼1.8×106 cells ml−1 in dynamic 3D culturing. In
2D, cells could expand ∼51-fold to generate
∼1.0×107 cells per well of the 6-well plate. In Alg-
Tubes, hPSCs expanded ∼500-fold to yield
∼5.0×108 cells ml−1 (figures 6(A) and (B)). Large
cell death was observed in static 3D, dynamic 3D and
2D culturing, especially after day 3 or when the cell
density reached ∼1.0×106 cells ml−1 (figures 6(D)
and (E)). In static 3D culturing, the % of dead cells
reached ∼43%, 53%, 59% and 62% on day 4, 5, 6 and
Figure 4. hPSCs retained pluripotency after long-term culturing inAlgTubes. After culturing inAlgTubes for 10 passages, H9-hESCs
could be differentiated into theNestin+ectodermal,α-SMA+mesodermal and FOXA2+endodermal cells in the EB assay (A);
form teratomas containing the three germ layer tissues in teratoma assay (B); and had normal karyotype (C). By further culturing in a
mesodermal or endodermal or cardiomyocyte differentiationmedium,H9-hESCs inAlgTubes could be differentiated into the
corresponding brachyury+mesodermal cells (D) or FOXA2+endodermal cells (E) or cTNT+cardiomyocytes (F). Fib-iPSCs and
MSC-iPSCs showed similar results (supplementary figure 10). Scale bar: (A), (B) 50 μm; (D)–(F) 100 μm.
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7, respectively. In dynamic 3D culturing, the%of dead
cells reached∼28%, 29%, 35% and 40% on day 4, 5, 6
and 7, respectively. In AlgTubes, cell death was low
and the % of dead cells was <10% during the entire
9 day culture. Cell cycle analysis showed static 3D,
dynamic 3D and 2D culturing did not decrease the %
of cells in proliferation (figure 6(C)). To study whether
the global gene expression are different, mRNAs of the
day 3 cells from the 4 culturing methods were
sequenced. On day 3, cell death was not significant and
majority of cells were proliferating in the 4 cultures
(figures 6(C)–(E)). Hierarchical clustering analysis
showed the gene expression profiles were very similar
between the 4 cultures (figures 6(F) and S12). These
results show that large cell death in 3D suspension cul-
turing leads to low culture efficiency, and the Alg-
Tubes improve the culture outcome through reducing
the cell death without significantly altering the global
gene expression and cell phenotype.
We also directly compared encapsulating and cul-
turing hPSCs in solid agarose, HA, and alginate hydro-
gels with suspending and culturing hPSCs in AlgTubes
(figure S13). When seeded at 1×106 cells ml−1, little
cell expansions were observed in HA and agarose
hydrogels. Small numbers of spheroids were formed
and hPSCs expanded ∼3.5-fold in solid alginate
hydrogel fibers. In AlgTubes, hPSCs expanded ∼500-
fold to yield∼5.0×108 cells ml−1. These results show
the importance of the free microspaces for achieving
high cell expansion and yield.
Discussion
Based on the results of culturing hPSCs in 2D, 3D
suspension and hydrogels [7, 17, 25–29], we proposed
that 3D culture microenvironments having free space
for the initial cell–cell interactions and subsequent cell
growth, but no cell agglomeration and hydrodynamic
stresses could significantly improve the culture effi-
ciency. The AlgTubes are designed to provide these
physiologically relevant microenvironments
(figures 1(A) and (B)). First, cells in AlgTubes are
protected from hydrodynamic stresses/conditions by
Figure 5.AnAlgTube-based prototype bioreactor. (A)AlgTubes with cells were suspended in a bioreactor.Mediumwas stored in a
plastic bellow bottle that could be pressed to flow themedium into, or released towithdraw themedium from the bioreactor. (B)
Images of themechanic stage for pressing and releasing the bellow bottle; the controller that can be programmed for the pressing and
releasing speed, as well as the duration of the interval between the pressing and releasing; and the bioreactor and bellow bottle. (C)
Image of the whitefibrous cellmass in the bioreactor on day 10. (D)∼1.0×109H9-hESCswere producedwith 2.0 mlAlgTubes on
day 10. (E)Confocalmicroscope images and (F)flow cytometry analysis showedmajority the cells on day 10 expressed pluripotency
markers: Nanog,Oct4, SSEA-4 and alkaline phosphatase (ALP). Scale bar: (C) 1 cm; (E) 100 μm.
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the hydrogel shells. This reduces the hydrodynamic-
conditions-induced negative effects [1, 15, 16, 21–23].
Second, cell masses in AlgTubes are controlled to be
less than 400 μm to ensure efficient mass transport
during the entire culture. Additionally, the cell masses
are monodisperse (in radial diameter), which can
improve the homogeneity of hPSC expansion and
differentiation. Other methods, such as culturing cells
with AggreWell™, can precisely control cell aggregate
size, however, are not scalable. Third, unlike encapsu-
lating and culturing cells in hydrogels (figure S13), the
AlgTubes provides free space for hPSC expansion and
does not hinder the initial cellular interaction, leading
to high volumetric yield and general applicability.
The use of alginates makes this new technology
scalable, cost-effective and GMP-compatible. Algi-
nates are affordable; available in large quantity; non-
toxic to cells; have been used in clinics; and can be
Figure 6.Adirect comparison of culturingH9-hESCs in 2D, 3D suspensionwithout agitation (static 3D), 3D suspensionwith
agitation (dynamic 3D) andAlgTubes. Cells were cultured for 7 days in 2D, static 3D and dynamic 3D culturing, and 9 days in
AlgTubes. (A)Expansion fold, (B) live cell density, (C)percentage of cells in S+G2/Mphases, and (D) the ratio of dead cells over
(dead cells+live cells) or%dead cells in the cultures were quantified. (E)%dead cells was also plotted versus live cell densities. Data
are presented asmean±SD of 3 (n=3 for (A)–(C)) or 5 (n=5 for (D), (E)) replicates. Seeded at 2.0×105 cells ml−1, H9-hESCs
expanded∼5- or 9-fold to yield amaximumof∼1.0 or 1.8×106 cells ml−1 in static or dynamic 3D suspension, respectively. Large
cell deathwas detected. Starting on day 4 or at 1.0×106 cells ml−1 live cell density, the%dead cells reached 40% to 60% for static 3D
suspension and 20%–40% for dynamic 3D suspension. Starting on day 4, cell death became significant in 2D culturing. InAlgTubes,
cells grew to∼5×108 cells ml−1 with low cell death. The%dead cells was<10%during the entire culture inAlgTubes. TheAlgTubes
did not enhance cells’ proliferation. (F)mRNAs of day 3 cells (3 biological replicates for each culturemethod)were sequenced.
Hierarchical clustering analysis of transcriptomes showed cells from the 4 culturemethods had similar gene expression profiles. Note
for 2D culturing, the unit for cell density in (B), (E) is cells/well (of 6-well plate).
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instantly crosslinked with Ca2+ ions to process large-
scale AlgTubes with the scalable extrusion technology
(figure S2) [35]. The resulting AlgTubes are mechani-
cally and chemically stable for months and suitable for
large-scale and long-term cell cultures; can be dis-
solved easily with cell-compatible EDTA solution to
release the product; and are transparent to allow
observation of cell growth [36].
The conceptual and technical innovations of Alg-
Tubes lead to high culture efficiency. We demon-
strated long-term culturing (>10 passages) ofmultiple
hPSC lines without uncontrolled differentiation and
chromosomal abnormalities (figures 3, S8 and S9).
Cultures between batches and cell lines were very con-
sistent (figure 3(A)). hPSCs in AlgTubes had high via-
bility, growth rate (1000-fold/10 days/passage in
general) and yield (∼5×108 cells ml−1 microspace).
The expansion per passage (e.g. up to 4200-fold/pas-
sage was achieved in figure S7) and volumetric yield
aremuch higher than current 3D suspension culturing
(table S1) [7, 8, 17, 37, 38]. For comparison, in 3D sus-
pension culturing, we typically achieve 4-fold expan-
sion per 4 days to yield around 2.0×106 cells ml−1.
As discussed later, the high yield and high expansion
fold have high impact on large-scale cell production
since they significantly reduce the culture volume and
time, numbers of passaging operations, and the pro-
duction cost. hPSCs could be efficiently differentiated
into various tissues cells (figure 4 and supplementary
video 2). In addition, AlgTubes-based scalable bior-
eactors could be readily built (figure 5). Our compara-
tive study showed the AlgTubes did not significantly
alter hPSCs’ gene expression profiles, but significantly
reduced cell death, resulting in high cell expansion and
yield (figures 6 and S12).
It should be noted that pluripotent stem cells have
been cultured in hollow fibers made from dry polymer
membranes [39–41]. However, their performance
offers no advancements over stirred-tank bioreactors.
In addition, harvesting cells from these fibers were
very challenging. For instance, it required treating the
cells with trypsin for 30–60 min.Moreover, cells could
not be observed with microscopy and sampling was
hard during the culture. Solid hydrogel fibers (e.g. not
hollow) have been studied for processing tissues
[42–44]. However, the AlgTubes are hollow and con-
ceptually and technically different from these systems.
The AlgTubes will be of broad interest to indivi-
dual laboratories, institutions, and biotechnology
companies working on regenerative medicine and
cancer therapies. First, AlgTubes provide laboratories
an easy-to-use tool for studying biology in 3D, which
can better replicate the in vivo biology than 2D cul-
tures [45]. For instance, AlgTubes may be used to cul-
ture organoids [46, 47], study cellular assembly into
tissues [48] and reprogram cells [49], etc. Second, the
AlgTubes can greatly benefit translational research.
Using hPSC-derived cardiomyocytes for treating
myocardial infarction as an example [50], 2D
culturing was first used for developing the differentia-
tion protocol and the initial demonstration of efficacy
and safety in rodents [51]. Subsequently, large effort
was spent to develop 3D suspension culturing for pre-
paring sufficient cardiomyocytes for tests on large ani-
mals [52, 53]. If successful, substantial amounts of
effort will be required to develop a new and large bio-
process formaking sufficient cells for clinical trials and
eventually clinics [50]. Since cell’s phenotype, safety
and efficacy are bioprocess-related, extensive and
expensive in vitro and in vivo characterization of cell
phenotype, safety, and efficacy are required after each
change of the culture method [54]. These efforts make
developing cellular therapeutics slow and expensive.
AlgTubes is scalable and can be used for culturing cells
for all these development stages. For instance,∼200 μl
AlgTubes can be used for developing the differentia-
tion protocol. ∼2 ml AlgTubes are sufficient to pro-
duce ∼109 cells for preclinical small animal studies.
∼200 ml AlgTubes can yield ∼1011 cells for tests on
large animals and clinical trials. The AlgTubes can save
significant time and investment for developing cellular
therapeutics. Third, the AlgTubes are very attractive
for industry-scale cell production. A simple compara-
tive calculation of producing ∼1.5×1014 hPSCs
(from ∼108 hPSC seeds) with stirred-tank bioreactors
and AlgTubes shows the significant impact of Alg-
Tubes’ high cell expansion per passage and volumetric
yield (figure S14). For the calculation, we assumed
4-fold expansion per 4 days per passage for stirred-
tank bioreactors and 1000-fold expansion per 10 days
per passage for AlgTubes as well as a seeding density of
5×105 cells ml−1 and a passaging efficiency (i.e., %
of cells remaining viable after one passaging) of 80%
for both. These assumptions are based on data from
my lab and others (table S1) [7, 17, 24, 55]. The pro-
duction requires ∼104, 811 liters of total culture
volume, 11 passaging operations, and 48 days with
stirred-tank bioreactors, which is technically and eco-
nomically challenging (figures S14(A) and (C)). As
mentioned, building large stirred-tank bioreactors will
be very challenging. Passaging is highly unwanted for
large-scale cell production since it requires large
amounts of time, labor, and reagent; increases the risk
of contamination and culture failure; loses large num-
bers of cells; and causes difficulties during automation.
The production can be done with 320 l of AlgTubes in
20 days and 1 passaging (figures S14(B) and (C)). The
reductions in culture volume, time, and passaging not
onlymake the production technically feasible, but also
lead to enormous cuts in labor, reagents, equipment,
cGMP facility size, and overall production cost.
In summary, the AlgTube technology combines
physiologically relevant culture microenvironments,
high performance, high scalability, cGMP compliance
and commercial viability, and has potential to address
the hPSC manufacturing challenge. Advances in biol-
ogy have developed protocols for efficiently differ-
entiating hPSCs into many human cell types [7, 31].
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Future research can explore integrating these proto-
cols into AlgTubes to produce various human cell
types. It will be valuable to systematically study cultur-
ing other cell types, such as human adult stem cells and
T cells in AlgTubes.
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